|
Volumn 29, Issue 11, 2008, Pages 386-397
|
Hormonal contraception for the adolescent
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
COPPER INTRAUTERINE DEVICE;
DESOGESTREL;
DROSPIRENONE;
DROSPIRENONE PLUS ETHINYLESTRADIOL;
ELCOMETRINE;
ESTRADIOL CYPIONATE PLUS MEDROXYPROGESTERONE ACETATE;
ESTROGEN;
ETHINYLESTRADIOL;
ETHINYLESTRADIOL PLUS ETONOGESTREL;
ETHINYLESTRADIOL PLUS LEVONORGESTREL;
ETHINYLESTRADIOL PLUS NORELGESTROMIN;
ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE;
ETONOGESTREL;
ETYNODIOL DIACETATE;
FEMCON FE;
FEMINENA;
GESTAGEN;
GESTODENE;
LEVONORGESTREL;
MEDROXYPROGESTERONE ACETATE;
MESTRANOL;
MIFEPRISTONE;
NORETHISTERONE;
NORETHISTERONE ACETATE;
NORETHISTERONE ENANTATE;
NORGESTIMATE;
NORGESTREL;
ORAL CONTRACEPTIVE AGENT;
UNCLASSIFIED DRUG;
ACNE;
ADOLESCENT;
ALLERGY;
APPLICATION SITE RASH;
ARTICLE;
BODY FAT;
BONE DENSITY;
BREAKTHROUGH BLEEDING;
BREAST DISCOMFORT;
BREAST ENGORGEMENT;
BREAST TENDERNESS;
CANCER RISK;
COUNSELING;
DISCOMFORT;
DIZZINESS;
DRUG CONTRAINDICATION;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
DYSMENORRHEA;
ECTOPIC PREGNANCY;
EMERGENCY CONTRACEPTION;
GENITAL BLEEDING;
HEADACHE;
HIRSUTISM;
HORMONAL CONTRACEPTION;
HUMAN;
HYPERKALEMIA;
INJECTION SITE PAIN;
INTRAUTERINE CONTRACEPTIVE DEVICE;
LEUKORRHEA;
MASTALGIA;
MENSTRUAL IRREGULARITY;
MIGRAINE;
MOOD;
NAUSEA;
NUASEA;
OVARY CANCER;
OVARY CYST;
OVARY POLYCYSTIC DISEASE;
PATIENT COMPLIANCE;
PHYSICIAN;
PREGNANCY;
PREMENSTRUAL SYNDROME;
PRIMARY MEDICAL CARE;
RISK REDUCTION;
SIDE EFFECT;
SKIN IRRITATION;
SPOTTING;
THROMBOEMBOLISM;
UNITED STATES;
UNSPECIFIED SIDE EFFECT;
UTERUS BLEEDING;
UTERUS CANCER;
VAGINA BLEEDING;
VAGINAL DISCOMFORT;
VAGINITIS;
VOMITING;
WEIGHT GAIN;
ADOLESCENT PREGNANCY;
ATTITUDE TO HEALTH;
CHILD BEHAVIOR;
CONTRACEPTION;
DOSE RESPONSE;
FEMALE;
HIGH RISK BEHAVIOR;
METHODOLOGY;
ORGANIZATION AND MANAGEMENT;
PHYSICIAN ATTITUDE;
PRIMARY HEALTH CARE;
REVIEW;
RISK ASSESSMENT;
SENSITIVITY AND SPECIFICITY;
SEXUAL EDUCATION;
STATISTICS;
ADOLESCENT;
ADOLESCENT BEHAVIOR;
ATTITUDE TO HEALTH;
CONTRACEPTION;
CONTRACEPTIVES, ORAL, COMBINED;
CONTRACEPTIVES, ORAL, HORMONAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HUMANS;
INTRAUTERINE DEVICES;
PATIENT COMPLIANCE;
PHYSICIAN'S ROLE;
PREGNANCY;
PREGNANCY IN ADOLESCENCE;
PRIMARY HEALTH CARE;
RISK ASSESSMENT;
RISK-TAKING;
SENSITIVITY AND SPECIFICITY;
SEX EDUCATION;
|
EID: 59849118291
PISSN: 01919601
EISSN: 15263347
Source Type: Journal
DOI: 10.1542/pir.29-11-386 Document Type: Article |
Times cited : (10)
|
References (15)
|